Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Mar 12;296(6624):731–732. doi: 10.1136/bmj.296.6624.731

β Blockers, lipids, and coronary atherosclerosis: fact or fiction?

Robin J Northcote
PMCID: PMC2545359  PMID: 2894885

Full text

PDF
731

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985 Jun 15;1(8442):1349–1354. doi: 10.1016/s0140-6736(85)91783-0. [DOI] [PubMed] [Google Scholar]
  2. Ballantyne D., Ballantyne F. C. Thiazides, beta blockers and lipoproteins. Postgrad Med J. 1983 Aug;59(694):483–488. doi: 10.1136/pgmj.59.694.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart-disease after treatment of hypertension. Lancet. 1978 Jan 7;1(8054):1–5. doi: 10.1016/s0140-6736(78)90356-2. [DOI] [PubMed] [Google Scholar]
  4. Carlson L. A., Böttiger L. E., Ahfeldt P. E. Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand. 1979;206(5):351–360. [PubMed] [Google Scholar]
  5. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  6. Chobanian A. V., Brecher P., Chan C. Effects of propranolol on atherogenesis in the cholesterol-fed rabbit. Circ Res. 1985 May;56(5):755–762. doi: 10.1161/01.res.56.5.755. [DOI] [PubMed] [Google Scholar]
  7. Compston J. E., Horton L. W., Laker M. F., Ayers A. B., Woodhead J. S., Bull H. J., Gazet J. C., Pilkington T. R. Bone disease after jejuno-ileal bypass for obesity. Lancet. 1978 Jul 1;2(8079):1–4. doi: 10.1016/s0140-6736(78)91318-1. [DOI] [PubMed] [Google Scholar]
  8. Coope J., Warrender T. S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1145–1151. doi: 10.1136/bmj.293.6555.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cruickshank J. M., Pennert K., Sörman A. E., Thorp J. M., Zacharias F. M., Zacharias F. J. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives. J Hypertens. 1987 Aug;5(4):489–498. [PubMed] [Google Scholar]
  10. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  11. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  12. Green K. G. Optimised blood-pressure. Lancet. 1979 Jul 7;2(8132):33–33. doi: 10.1016/s0140-6736(79)90191-0. [DOI] [PubMed] [Google Scholar]
  13. Green K. G. The role of hypertension and downward changes of blood pressure in the genesis of coronary atherosclerosis and acute myocardial ischemic attacks. Am Heart J. 1982 Apr;103(4 Pt 1):579–582. doi: 10.1016/0002-8703(82)90353-2. [DOI] [PubMed] [Google Scholar]
  14. Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J. 1978 Aug 5;2(6134):403–403. doi: 10.1136/bmj.2.6134.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  16. Marlin G. E., Thompson P. J., Reddel H. K., Chow C. M., Cheng S. Bronchodilator activity of prazosin in patients with allergic rhinitis and asthma. Br J Clin Pharmacol. 1982 Mar;13(3):445–448. doi: 10.1111/j.1365-2125.1982.tb01400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  18. Northcote R. J., Ballantyne D. Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions. Clin Sci (Lond) 1987 May;72(5):549–556. doi: 10.1042/cs0720549. [DOI] [PubMed] [Google Scholar]
  19. Northcote R. J., Todd I. C., Ballantyne D. Beta blockers and lipoproteins: a review of current knowledge. Scott Med J. 1986 Oct;31(4):220–228. doi: 10.1177/003693308603100402. [DOI] [PubMed] [Google Scholar]
  20. Shaw J., England J. D., Hua A. S. Beta-blockers and plasma triglycerides. Br Med J. 1978 Apr 15;1(6118):986–986. doi: 10.1136/bmj.1.6118.986-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Whittington-Coleman P. J., Carrier O., Jr, Douglas B. H. The effects of propranolol on cholesterol-induced atheromatous lesions. Atherosclerosis. 1973 Sep-Oct;18(2):337–345. doi: 10.1016/0021-9150(73)90109-3. [DOI] [PubMed] [Google Scholar]
  22. Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973 Nov;48(5):950–958. doi: 10.1161/01.cir.48.5.950. [DOI] [PubMed] [Google Scholar]
  23. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES